View Older Stories
-
Teladoc (TDOC) Misses Q1 EPS by 2c ; Offers Guidance
-
Grabar Law Office Investigates Claims on Behalf of Long-Term Investors of Teladoc Health, Inc. (TDOC) as Class Action Survives Motion to Dismiss
-
Pineal Capital pushes TELADOC for buybacks and strategic review
-
Deutsche Bank Upgrades Teladoc (TDOC) to Buy
-
Teladoc (TDOC) PT Raised to $8.25 at BofA Securities
-
BofA Securities Upgrades Teladoc (TDOC) to Buy
-
Teladoc (TDOC) PT Lowered to $6 at Stifel Following Q4 Results
-
Teladoc (TDOC) PT Lowered to $5 at BMO Capital
-
Teladoc (TDOC) PT Lowered to $6 at Wells Fargo
-
Teladoc (TDOC) Tops Q4 EPS by 4c, provides guidance
-
Teladoc (TDOC) PT Lowered to $7 at BofA Securities
-
Stifel Reiterates Hold Rating on Teladoc (TDOC) After 24/7 Care Enhancement Announced
-
Teladoc (TDOC) PT Lowered to $7.50 at BofA Securities
-
Teladoc board member Evans to retire in 2026
-
Teladoc (TDOC) 20K contracts of December 5 weekly 8 calls trade
-
Teladoc (TDOC) November 28 weekly 7.5 and December 7.5 calls active as share price up 3.8%
-
Stifel Reiterates Hold Rating on Teladoc (TDOC)
-
Teladoc (TDOC) Misses Q3 EPS by 2c, provides guidance
-
After-hours movers: Ford, Intel, Deckers Brands, and more
-
Teladoc (TDOC) Mentioned as Positive Again at Citron Research
-
Stifel Reiterates Hold Rating on Teladoc (TDOC)
-
Teladoc (TDOC) PT Lowered to $10 at Cantor Fitzgerald
-
Needham Reiterates Hold Rating on Teladoc (TDOC)
-
After-hours movers: Starbucks, Seagate Technology, Teladoc and more
-
Teladoc (TDOC) Tops Q2 EPS by 7c, Offers Guidance
-
Mizuho Starts Teladoc (TDOC) at Neutral
-
Teladoc (TDOC) Mentioned as Positive at Citron Research
-
Teladoc (TDOC) PT Lowered to $7 at BofA Securities
-
Teladoc (TDOC) PT Lowered to $9 at Truist Securities
-
Teladoc (TDOC) PT Lowered to $12 at Canaccord Genuity
-
Teladoc (TDOC) PT Lowered to $8 at Citi
-
After-hours movers: Meta, Microsoft, Qualcomm and more
-
Teladoc (TDOC) Misses Q1 EPS by 19c, provides guidance
-
Teladoc (TDOC) Acquires UpLift
-
Teladoc (TDOC) PT Lowered to $8 at Stephens
-
Teladoc (TDOC) PT Lowered to $8 at Jefferies
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
Truist Securities Reiterates Hold Rating on Teladoc (TDOC)
-
Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly
-
Teladoc (TDOC) announces inducement awards to 21 new employees
-
Stifel Reiterates Hold Rating on Teladoc (TDOC)
-
Needham Reiterates Hold Rating on Teladoc (TDOC)
-
After-hours movers: NVIDIA, Salesforce, eBay and more
-
Teladoc (TDOC) Misses Q4 EPS by 5c
-
Teladoc Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
-
Teladoc (TDOC) Mentioned as Short at Blue Orca
-
Teladoc (TDOC) PT Raised to $13.50 at BofA Securities
-
Teladoc (TDOC) is Under-the-Radar AI Play - Citron Research
-
Needham Reiterates Hold Rating on Teladoc (TDOC)

